MARMARA MEDICAL JOURNAL, cilt.33, sa.2, ss.83-89, 2020 (ESCI)
Objective: The cases of diffuse large B-cell lymphoma, (DLBCL not otherwise specified (NOS)) which immunohistochemically exhibit MYC and BCL2 expressions arc defined as double-expressor lymphomas (DELs). This study aimed to assess the prognostic impact of DEL and the expressions of other proteins that may have role in tumorogenesis.